Vitamin D and Hypertensive Disorders of Pregnancy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorTriHealth Inc.

About this trial

The purpose of this study is to further investigate the association between vitamin D deficiency/insufficiency and hypertensive disorders of pregnancy by studying the impact of screening for vitamin D deficiency and supplementation when low levels of vitamin D are detected. Screening for vitamin D deficiency (less than 20 ng/mL) and insufficiency (less than 30 ng/mL) may determine the need for additional supplementation, as most prenatal vitamins only contain 400 IU of vitamin D. The rates of hypertensive disorders of pregnancy amongst patients who received supplementation and maintained adequate vitamin D levels will be followed.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnant women

18-45 years old

Receiving care at outpatient OB office of TriHealth's Women's Services Comprehensive OB-GYN Team with a plan to deliver at Bethesda North Hospital

Disqualifiers

Non-English speaking

Unable to provide consent to research study participation

Diagnosis of preexisting renal disease

Diagnoses of preexisting chronic hypertension

Trial design

Design model

Single group

Treatments tested in this trial

  • Vitamin D Levels measurement

    Diagnostic test

    Patient will have a vitamin D level drawn with their other prenatal labs during an OB visit. If vitamin D insufficiency (less than 30 ng/mL) or deficiency (less than 20 ng/mL) is detected, the patient will be prescribed and provided a supplementation of 2000 IU of vitamin D daily for the remainder of the pregnancy.

Treatment groups

594 Participants
are divided into 2 treatment groups
Group A: Arm 1: Standard OB care with no screening for vitamin D level.No intervention 0 interventions
Group B: Arm 2: Vitamin D screening and supplementation if neededExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Hypertensive disorders of pregnancy

Was patient diagnosed with a hypertensive disorder of pregnancy (preeclampsia or GHTN) per clinician judgement based on ACOG guidelines

Time frame
During pregnancy, up to 9 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: